Oh E - Search Results

1

Comprehensive Characterization of Oncogenic Drivers in Asian Lung Adenocarcinoma.

Li S, Choi YL, Gong Z, Liu X, Lira M, Kan Z, Oh E, Wang J, Ting JC, Ye X, Reinhart C, Liu X, Pei Y, Zhou W, Chen R, Fu S, Jin G, Jiang A, Fernandez J, Hardwick J, Kang MW, I H, Zheng H, Kim J, Mao M. Li S, et al. Among authors: oh e. J Thorac Oncol. 2016 Dec;11(12):2129-2140. doi: 10.1016/j.jtho.2016.08.142. Epub 2016 Sep 9. J Thorac Oncol. 2016. PMID: 27615396 Free article.

2

HIP1-ALK, a novel fusion protein identified in lung adenocarcinoma.

Hong M, Kim RN, Song JY, Choi SJ, Oh E, Lira ME, Mao M, Takeuchi K, Han J, Kim J, Choi YL. Hong M, et al. Among authors: oh e. J Thorac Oncol. 2014 Mar;9(3):419-22. doi: 10.1097/JTO.0000000000000061. J Thorac Oncol. 2014. PMID: 24518094 Free article.

3

MET Exon 14 Skipping Mutations in Lung Adenocarcinoma: Clinicopathologic Implications and Prognostic Values.

Lee GD, Lee SE, Oh DY, Yu DB, Jeong HM, Kim J, Hong S, Jung HS, Oh E, Song JY, Lee MS, Kim M, Jung K, Kim J, Shin YK, Choi YL, Kim HR. Lee GD, et al. Among authors: oh dy, oh e. J Thorac Oncol. 2017 Aug;12(8):1233-1246. doi: 10.1016/j.jtho.2017.04.031. Epub 2017 May 10. J Thorac Oncol. 2017. PMID: 28502721 Free article.

4

Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification.

Oh DY, Jung K, Song JY, Kim S, Shin S, Kwon YJ, Oh E, Park WY, Song SY, Choi YL. Oh DY, et al. Among authors: oh e. BMC Cancer. 2017 Aug 10;17(1):535. doi: 10.1186/s12885-017-3525-9. BMC Cancer. 2017. PMID: 28806950 Free PMC article.

5

LYN expression predicts the response to dasatinib in a subpopulation of lung adenocarcinoma patients.

Kim YJ, Hong S, Sung M, Park MJ, Jung K, Noh KW, Oh DY, Lee MS, Oh E, Shin YK, Choi YL. Kim YJ, et al. Among authors: oh dy, oh e. Oncotarget. 2016 Dec 13;7(50):82876-82888. doi: 10.18632/oncotarget.12657. Oncotarget. 2016. PMID: 27756880 Free PMC article.

6

Aberrant CDK4 amplification in refractory rhabdomyosarcoma as identified by genomic profiling.

Park S, Lee J, Do IG, Jang J, Rho K, Ahn S, Maruja L, Kim SJ, Kim KM, Mao M, Oh E, Kim YJ, Kim J, Choi YL. Park S, et al. Among authors: oh e. Sci Rep. 2014 Jan 10;4:3623. doi: 10.1038/srep03623. Sci Rep. 2014. PMID: 24406431 Free PMC article.

7

Engrailed 1 overexpression as a potential prognostic marker in quintuple-negative breast cancer.

Kim YJ, Sung M, Oh E, Vrancken MV, Song JY, Jung K, Choi YL. Kim YJ, et al. Among authors: oh e. Cancer Biol Ther. 2018 Apr 3;19(4):335-345. doi: 10.1080/15384047.2018.1423913. Epub 2018 Feb 13. Cancer Biol Ther. 2018. PMID: 29333926 Free PMC article.

8

Comparison of Accuracy of Whole-Exome Sequencing with Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tissue Samples.

Oh E, Choi YL, Kwon MJ, Kim RN, Kim YJ, Song JY, Jung KS, Shin YK. Oh E, et al. PLoS One. 2015 Dec 7;10(12):e0144162. doi: 10.1371/journal.pone.0144162. eCollection 2015. PLoS One. 2015. PMID: 26641479 Free PMC article.

9

Low SP1 expression differentially affects intestinal-type compared with diffuse-type gastric adenocarcinoma.

Lee HS, Park CK, Oh E, Erkin ÖC, Jung HS, Cho MH, Kwon MJ, Chae SW, Kim SH, Wang LH, Park MJ, Lee SY, Yang HB, Jia L, Choi YL, Shin YK. Lee HS, et al. Among authors: oh e. PLoS One. 2013;8(2):e55522. doi: 10.1371/journal.pone.0055522. Epub 2013 Feb 20. PLoS One. 2013. PMID: 23437057 Free PMC article.

10

Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors.

Cho YB, Hong HK, Choi YL, Oh E, Joo KM, Jin J, Nam DH, Ko YH, Lee WY. Cho YB, et al. Among authors: oh e. J Surg Res. 2014 Apr;187(2):502-9. doi: 10.1016/j.jss.2013.11.010. Epub 2013 Nov 15. J Surg Res. 2014. PMID: 24332554

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,046 results

Search Page